Find A PhysicianHome  |  Library  |  myDownstate  |  Newsroom  |  A-Z Guide  |  E-mail  |  Contact Us  |  Directions

SUNY Downstate Medical Center

Department of Pathology

Profile

Charles Y. Shao, MD, PhD

Charles Y. Shao, MD, PhD

Clinical Associate Professor

Department of Pathology
Division of Surgical and Neuropathology

Tel: (718) 245-5374

e-mail: charles.shao@downstate.edu

Education and Training
  • 1983. M.D., Capital University of Medical Science, Beijing, China.
  • 1985-1990. Ph.D., Emory University School of Medicine, Atlanta, GA
  • 1990-1995. Postdoc. University of North Carolina at Chapel Hill, NC
  • 1995-1997. Alzheimer's Disease Center, Emory University School of Medicine.
  • 1997-2001. Resident/Fellow, AP/NP, Department of Pathology, New York University Medical Center, NY
Committees , Council, and Professional Society Memberships
  • American Association of Neuropathologists, 2002-present
  • American Medical Association, 1998-present
  • College of American Pathologists, 1997-present
  • Society for Neuroscience, 1985-1997, 2002-present
Research Interest Summary

I am interested in the pathogenesis of neurodegenerative diseases, especially Alzheimer's Disease (AD) the most common form of memory disorders. Accumulating evidence has indicated that synaptic plasticity such as long-term potentiation (LTP) that underlines learning and memory is impaired in AD. I currently focus on an unique molecule called PKMzeta that plays a critical role in LTP maintenance and memory function in living animals. I have found that PKMzeta associates with a variety of AD pathology that mark changes of postsynaptic structures such as Hirano bodies (dendritic spines), perisomatic granules (AMPA receptors) and granulovacular degeneration. I postulate that PKMzeta regulate these structures during memory formation and their aggregation during AD lead to memory loss. Using primary cultures of hippocampal neurons, I demonstrate that PKMzeta indeed positively regulates synaptic structures and AMPA receptors. Further studies will explore what alters PKMzeta in neurons and how PKMzeta may play a role in combating AD.

figure

PKMzeta in AD hippocampal pathology. a. Hirano body (HB). b. Granulovacuolar degeneration (GVD). c. Perisomatic granules (PSG) are immunoreactive for anti-GluR2 antibody. d-f. PKMzeta immunoreactivity in HB, GVD and PSG.

  • Shao, C.Y., R. Sondhi, T.C. Sacktor, PKMzeta regulates PSD-95 and AMPA receptor trafficking in hippocampal neurons. 2007 Society for Neuroscience. Abstract.
  • Shao, Charles Y., Rachna Sondhi, William Oxberry, Matthew T. Kelly, Suzanne . Mirra, Todd C. Sacktor. Protein kinase M zeta regulates AMPA receptors on hippocampal neurons linking long term synaptic plasticity to Alzheimer's disease. Brain Pathology 2006; 16:s159
  • Shao CY, Crary JF, Rao C, Sacktor TC, Mirra SS. Atypical Protein Kinase C in Neurodegenerative Disease II: PKCi/l in Tauopathies and a-Synucleinopathies. J. Neuropath. Exp. Neurol. 2006; 65:327-335.
  • Crary JF*, Shao CY*, Mirra SS, Hernandez AI, Sacktor TC. Atypical Protein Kinase C in Neurodegenerative Disease I: PKMzeta Aggregates with Limbic Neurofibrillary Tangles and AMPA Receptors in Alzheimer's Disease. J. Neuropath. Exp. Neurol. 2006; 65:319-326. *equal contributions
  • Shao, Y., M. Gearing, and S. S. Mirra. Astrocyte-apolipoprotein E (apoE) associations in senile plaques in Alzheimer's disease and vascular lesions: A regional immunohistochemical study. J. Neuropath. Exp. Neurol. 1997; 56:376-381.
  • Shao, Y. and K.D. McCarthy Responses of Bergmann glia and granule neurons in situ to N-methyl-D-aspartate, norepinephrine and high potassium: Implication of neuron-glia interaction. J. Neurochemistry 1997; 68:2405-2411
  • Shao, Y. and K.D. McCarthy Receptor-mediated calcium signals in astroglia: Multiple receptors, common stores and all-or-nothing responses. Cell Calcium 1995; 17:187-196